Tiagabine and exacerbation of essential tremor. Publication: Journal Article Zesiewicz, TA, CL Ward, and RA Hauser. 2007. “Tiagabine and Exacerbation of Essential Tremor.”. Mov Disord.
Role of the pharmacist in the effective management of wearing-off in Parkinson’s disease. Publication: Journal Article Simonson, W, RA Hauser, and AH Shapira. 2007. “Role of the Pharmacist in the Effective Management of Wearing-off in Parkinson’s Disease.”. Ann Pharmacother.
Ten-year follow-up of Parkinson’s disease patients randomized to initial therapy with ropinirole or levodopa. Publication: Journal Article Hauser, RA, O Rascol, AD Korczyn, Jon Stoessl, RL Watts, W Poewe, PP De Deyn, and AE Lang. 2007. “Ten-Year Follow-up of Parkinson’s Disease Patients Randomized to Initial Therapy With Ropinirole or Levodopa.”. Mov Disord.
Tegaserod (Zelnorm) for the treatment of constipation in Parkinson’s disease. Publication: Journal Article Sullivan, KL, JK Staffetti, RA Hauser, PB Dunne, and TA Zesiewicz. 2006. “Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease.”. Movement Disorders.
Clinical trials aimed at detecting neuroprotection in Parkinson’s disease. Publication: Journal Article Hauser, RA, and T Zesiewicz. 2006. “Clinical Trials Aimed at Detecting Neuroprotection in Parkinson’s Disease.”. Neurology.
Use of nutritional supplements in Parkinson’s disease patients. Publication: Journal Article Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.
Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch Neurol 2006;63:1181-1184. Publication: Journal Article Graff-Radford, J, KD Foote, RL Rodriguez, HH Fernandez, RA Hauser, and . 2006. “Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia. Arch Neurol 2006;63:1181-1184.”. Arch Neurol.
Levodopa/carbidopa/entacapone for the treatment of Parkinson’s disease. Publication: Journal Article Samanta, J, and RA Hauser. 2006. “Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease.”. Aging Health.
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson’s disease. Publication: Journal Article Hauser, RA, MP McDermott, S Messing, and Parkinson Study Group. 2006. “Factors Associated With the Development of Motor Fluctuations and Dyskinesias in Parkinson’s Disease.”. Arch Neurol.
Nonmotor symptoms of Parkinson’s disease. Publication: Journal Article Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Nonmotor Symptoms of Parkinson’s Disease.”. Expert Rev Neurother.